These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7540920)

  • 1. Cell transfer therapy of cancer metastasis with autologous lymphocytes.
    Mikamo S; Sekiguchi M
    Cell Transplant; 1995; 4 Suppl 1():S65-7. PubMed ID: 7540920
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of autologous tumor-specific cytotoxic T cells in patients with liver cancer. Characterizations and clinical utilization.
    Aruga A; Yamauchi K; Takasaki K; Furukawa T; Hanyu F
    Int J Cancer; 1991 Aug; 49(1):19-24. PubMed ID: 1678733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
    Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
    Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant activation of CD8+ T-cell and CD8+ T-cell subsets in patients with newly diagnosed IDDM.
    Hehmke B; Michaelis D; Gens E; Laube F; Kohnert KD
    Diabetes; 1995 Dec; 44(12):1414-9. PubMed ID: 7589848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
    Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
    J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.
    Rosenberg SA; Lotze MT; Muul LM; Leitman S; Chang AE; Ettinghausen SE; Matory YL; Skibber JM; Shiloni E; Vetto JT
    N Engl J Med; 1985 Dec; 313(23):1485-92. PubMed ID: 3903508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells.
    Müller B; Fischer B; Kreutz W
    Immunology; 2000 Mar; 99(3):375-84. PubMed ID: 10712667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
    Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
    Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of liver-associated lymphocytes in patients with liver metastasis.
    Winnock M; Garcia-Barcina M; Huet S; Bernard P; Saric J; Bioulac-Sage P; Gualde N; Balabaud C
    Gastroenterology; 1993 Oct; 105(4):1152-8. PubMed ID: 7691673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of lymphokine-activated killer cells obtained from the natural killers--T cells of patients with hepatic tumor lesion].
    Vershinina MIu; Khalturina EO; Patiutko IuI; Zabezhinskiĭ DA; Titov KS; Lebedinskaia OV; Vorob'ev AA; Kiselevskiĭ MV; Kuzovlev EN
    Vestn Ross Akad Med Nauk; 2004; (12):32-6. PubMed ID: 15678686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of human tumor-infiltrating lymphocytes expanded in hollow-fiber bioreactors for immunotherapy of cancer.
    Malone CC; Schiltz PM; Mackintosh AD; Beutel LD; Heinemann FS; Dillman RO
    Cancer Biother Radiopharm; 2001 Oct; 16(5):381-90. PubMed ID: 11776755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with simultaneous absence of "classical" natural killer cells (CD3-, CD16+, and NKH1+) and expansion of CD3+, CD4-, CD8-, NKH1+ subset.
    Ballas ZK; Turner JM; Turner DA; Goetzman EA; Kemp JD
    J Allergy Clin Immunol; 1990 Feb; 85(2):453-9. PubMed ID: 2303649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
    Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
    J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in peripheral blood lymphocyte count in dogs following adoptive immunotherapy using lymphokine-activated T killer cells combined with palliative tumor resection.
    Mie K; Shimada T; Akiyoshi H; Hayashi A; Ohashi F
    Vet Immunol Immunopathol; 2016 Sep; 177():58-63. PubMed ID: 27436446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.